Gilead Sciences
GILD
#131
Rank
$148.10 B
Marketcap
$119.36
Share price
-1.51%
Change (1 day)
34.75%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : $7.34 Billion USD

According to Gilead Sciences's latest financial reports the company has $7.34 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$11.56 B59.25%
2023-12-31$7.26 B13.77%
2022-12-31$6.38 B-2.07%
2021-12-31$6.52 B-11.99%
2020-12-31$7.40 B-69.58%
2019-12-31$24.35 B-19.07%
2018-12-31$30.08 B17.95%
2017-12-31$25.51 B114.46%
2016-12-31$11.89 B-18.57%
2015-12-31$14.60 B44.22%
2014-12-31$10.12 B375.05%
2013-12-31$2.13 B14.49%
2012-12-31$1.86 B-81.19%
2011-12-31$9.90 B371.74%
2010-12-31$2.09 B26.66%
2009-12-31$1.65 B-7.43%
2008-12-31$1.79 B52.74%
2007-12-31$1.17 B25.1%
2006-12-31$0.93 B-59.46%
2005-12-31$2.31 B84.29%
2004-12-31$1.25 B77.37%
2003-12-31$0.70 B-24.98%
2002-12-31$0.94 B61.68%
2001-12-31$0.58 B13.64%
2000-12-31$0.51 B74.21%
1999-12-31$0.29 B191.19%
1998-12-31$0.10 B215.94%
1997-12-31$32 M-75.76%
1996-12-31$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
$9.44 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$6.28 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$5.67 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.27 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.96 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$18.56 B 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$9.91 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA